Keywords: alexion, plans, pivotal, pexelizumab, trial, pharmaceuticals, usa

Alexion plans pivotal pexelizumab trial

Article | 15 November 2001

Print This

Alexion Pharmaceuticals of the USA has announced plans to start a PhaseIII trial of pexelizumab in around 3,000 patients undergoing coronary ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in